Press release
Rising Prevalence Of Osteoporosis Fuels Growth In The Osteoporosis Drug Market: A Significant Driver Propelling The Osteoporosis Drugs Market In 2025
Osteoporosis Drugs
What Is the Expected Osteoporosis Drugs Market Size During the Forecast Period?
The market for medications for osteoporosis has seen a consistent rise in recent years. The current market value of $12.33 billion in 2024 is projected to increase to $12.8 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 3.8%. Factors contributing to this growth in the previous period include an aging population, heightened awareness and diagnosis, lifestyle factors, governmental initiatives, and changes in healTH*Care policies.
The market for osteoporosis medications is projected to experience consistent expansion in the near future, escalating to a value of $14.48 billion by 2029, with a compound annual growth rate (CAGR) of 3.1%. This growth within the forecasted period can be linked to the continuous increase in the aging population, improvement in treatment choices, amplified emphasis on male bone health, patient knowledge and empowerment, global health policies, and insurance coverage. Critical trends during this period entail personalized medicine techniques, investigation of combined therapies, focus on methods to prevent fractures, research and development investments in new drug goals, and partnerships for drug development.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9102
What Are the High-Growth Segments in the Osteoporosis Drugs Market?
The osteoporosis drugs market covered in this report is segmented -
1) By Type: Bisphosphonates, Selective Estrogen Receptor Modulators (SERMs), RANK Ligand Inhibitors
2) By Administration: Oral, Injectable
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Sales
4) By Application: Primary Osteoporosis, Secondary Osteoporosis
Subsegments:
1) By Bisphosphonates: Alendronate, Risedronate, Ibandronate, Zoledronic Acid
2) By Selective Estrogen Receptor Modulators (SERMs): Raloxifene, Bazedoxifene
3) By RANK Ligand Inhibitors: Denosumab
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9102&type=smp
What Key Drivers Are Expected to Influence Future Osteoporosis Drugs Market Growth?
The rise in osteoporosis incidence is anticipated to fuel the osteoporosis drug market's expansion. Osteoporosis, a bone disorder, happens when there is a reduction in bone mineral density, mass bone, or alterations in bone quality or structure. Those with a deficient calcium intake are more at risk of contracting osteoporosis. Drugs for osteoporosis increase bone mineral density and assist in avoiding fractures. For example, in June 2024, the Australian Institute of Health and Welfare Australia-Government agency documented that osteoporosis was responsible for 2,659 deaths in 2022, which is equivalent to 10.2 deaths per 100,000 population, or 1.4% of total deaths. Thus, the escalating prevalence of osteoporosis is propelling the osteoporosis drugs market's growth.
Which Companies Hold the Largest Share Across Different Osteoporosis Drugs Market Segments?
Major companies operating in the osteoporosis drugs market include Pfizer Inc., F. Hoffmann La Roche Ltd., Merck & Co Inc., Novartis AG, Bristol Myers Squibb Company, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Asahi Kasei Pharma Corporation, Viatris Inc., Teva Pharmaceutical Industries Ltd, Mylan N.V., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Ipsen, Kyowa Kirin Co Ltd., Dr. Reddy's Laboratories Ltd., Cipla Limited, Recordati S.p.A., Cadila HealTH*Care Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Sunovion Pharmaceuticals Inc., Theramex, Radius Health Inc., Strides Pharma Science Limited, Apotex Inc.
What Are the Latest Developing Trends in the Osteoporosis Drugs Market?
Leading firms in the osteoporosis drugs market are progressing with the implementation of innovative approaches in this sector. For example, Apotex Inc., a pharmaceutical entity based in Canada, introduced Teriparatide Injectable for treating osteoporosis in November 2023. This injection, a pre-filled pen packed with 250 mcg/mL, can deliver 28 daily doses of 20 mcg per pen and is intended to be used by a single patient. Such a product will provide necessary and affordably accessible treatment for patients.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report
What Are the Emerging Geographies for The Osteoporosis Drugs Market Growth?
North America was the largest region in the osteoporosis market in 2024. The regions covered in the osteoporosis drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Osteoporosis Drugs Market?
2. What is the CAGR expected in the Osteoporosis Drugs Market?
3. What Are the Key Innovations Transforming the Osteoporosis Drugs Industry?
4. Which Region Is Leading the Osteoporosis Drugs Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Prevalence Of Osteoporosis Fuels Growth In The Osteoporosis Drug Market: A Significant Driver Propelling The Osteoporosis Drugs Market In 2025 here
News-ID: 4015453 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Osteoporosis
Rising Prevalence Of Osteoporosis Fuels Growth In Osteoporosis Treatment Market: …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Osteoporosis Treatment Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the realm of osteoporosis treatments, the market has seen consistent expansion recently, projected to increase its valuation from $13.96 billion in 2024 to $14.57 billion come 2025, reflecting a compound annual growth rate of…
Rising Prevalence Of Osteoporosis Spurs Momentum In Postmenopausal Osteoporosis …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Postmenopausal Osteoporosis Treatment Market Through 2025?
Valuations for the marketplace addressing postmenopausal osteoporosis treatments have demonstrated consistent upward movement throughout the preceding years, projecting an expansion from a figure of $10.1 billion in 2024 to an anticipated $10.54 billion by 2025, reflecting…
Rising Prevalence Of Osteoporosis Spurs Momentum In Postmenopausal Osteoporosis …
The Postmenopausal Osteoporosis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Postmenopausal Osteoporosis Treatment Market Size and Its Estimated Growth Rate?
The market for treatment of postmenopausal osteoporosis has seen a steady increase in size over the recent years. It's projected…
Osteoporosis Drug Market, By Type (Primary Osteoporosis and Secondary Osteoporos …
Osteoporosis is a condition of bone weakening or bones becomes fragile and likely to break. In other words, osteoporosis is a condition wherein the bone density decreases. This is specially witnessed in old age people. Osteoporosis brings along back pain, stooped posture, bone fracture and tooth loss.
View Detailed Report" https://www.databridgemarketresearch.com/reports/global-osteoporosis-drug-market
The global osteoporosis drug market is experiencing steady growth driven by factors such as the increasing aging population, rising prevalence of…
Osteoporosis Drugs Market: Demand for Osteoporosis Drugs High Among Geriatric Po …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.…
Rising Prevalence of Osteoporosis and Aging Population Boosts the Growth of Oste …
Osteoporosis is a chronic and life-threatening disease, in which microstructure of bones is altered due to reduction in bone mass and bone density. This condition leads to increased bone fragility and threat of bone cracks and fractures. Thus, osteoporosis is considered life threatening due to severe injury and associated pain. The osteoporosis drugs market report studies the current scenario as well as the future market potential for osteoporosis drugs globally.…
